Racial differences in oxidative stress and inflammation

In vitro and in vivo

Deborah L. Feairheller, Joon Young Park, Kathleen Sturgeon, Sheara T. Williamson, Keith M. Diaz, Praveen Veerabhadrappa, Michael D. Brown

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

African American race is an independent risk factor for enhanced oxidative stress and inflammation. We sought to examine whether oxidative-stress and inflammatory markers that are typically measured in humans also differ by race in cell culture. We compared levels between African American and Caucasian young adults and then separately in human umbilical vein endothelial cells (HUVECs) from both races. We found heightened oxidative stress and inflammation in the African Americans both in vitroand in vivo. African American HUVECs showed higher nitric oxide (NO) levels (10.8 ± 0.4 vs. 8.8 ± 0.7 μmol/L/mg, p= 0.03), Interleukin-6 (IL-6) levels (61.7 ± 4.2 vs. 23.9 ± 9.0 pg/mg, p= 0.02), and lower superoxide dismutase activity (15.6 ± 3.3 vs. 25.4 ± 2.8 U/mg, p= 0.04), and also higher protein expression (p< 0.05) of NADPH oxidase subunit p47phox, isoforms NOX2 and NOX4, endothelial nitric oxide synthase (NOS), inducible NOS, as well as IL-6. African American adults had higher plasma protein carbonyls (1.1 ± 0.1 vs. 0.8 ± 0.1 nmol/mg, p= 0.01) and antioxidant capacity (2.3 ± 0.2 vs. 1.1 ± 0.3 mM, p= 0.01). These preliminary translational data demonstrate a racial difference in HUVECs much like that in humans, but should be interpreted with caution given its preliminary nature. It is known that racial differences exist in how humans respond to development and progression of disease, therefore these data suggest that ethnicity of cell model may be important to consider with in vitroclinical research.

Original languageEnglish (US)
Pages (from-to)32-37
Number of pages6
JournalClinical and Translational Science
Volume4
Issue number1
DOIs
StatePublished - Feb 1 2011

Fingerprint

Oxidative stress
Endothelial cells
African Americans
Oxidative Stress
Inflammation
Human Umbilical Vein Endothelial Cells
Interleukin-6
Nitric Oxide Synthase Type III
NADPH Oxidase
Nitric Oxide Synthase Type II
Cell culture
Superoxide Dismutase
Blood Proteins
Nitric Oxide
Protein Isoforms
Antioxidants
Disease Progression
Young Adult
Cell Culture Techniques
In Vitro Techniques

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Feairheller, Deborah L. ; Park, Joon Young ; Sturgeon, Kathleen ; Williamson, Sheara T. ; Diaz, Keith M. ; Veerabhadrappa, Praveen ; Brown, Michael D. / Racial differences in oxidative stress and inflammation : In vitro and in vivo. In: Clinical and Translational Science. 2011 ; Vol. 4, No. 1. pp. 32-37.
@article{07c5e45cf9e94ae1b3ef3a921ef1ed75,
title = "Racial differences in oxidative stress and inflammation: In vitro and in vivo",
abstract = "African American race is an independent risk factor for enhanced oxidative stress and inflammation. We sought to examine whether oxidative-stress and inflammatory markers that are typically measured in humans also differ by race in cell culture. We compared levels between African American and Caucasian young adults and then separately in human umbilical vein endothelial cells (HUVECs) from both races. We found heightened oxidative stress and inflammation in the African Americans both in vitroand in vivo. African American HUVECs showed higher nitric oxide (NO) levels (10.8 ± 0.4 vs. 8.8 ± 0.7 μmol/L/mg, p= 0.03), Interleukin-6 (IL-6) levels (61.7 ± 4.2 vs. 23.9 ± 9.0 pg/mg, p= 0.02), and lower superoxide dismutase activity (15.6 ± 3.3 vs. 25.4 ± 2.8 U/mg, p= 0.04), and also higher protein expression (p< 0.05) of NADPH oxidase subunit p47phox, isoforms NOX2 and NOX4, endothelial nitric oxide synthase (NOS), inducible NOS, as well as IL-6. African American adults had higher plasma protein carbonyls (1.1 ± 0.1 vs. 0.8 ± 0.1 nmol/mg, p= 0.01) and antioxidant capacity (2.3 ± 0.2 vs. 1.1 ± 0.3 mM, p= 0.01). These preliminary translational data demonstrate a racial difference in HUVECs much like that in humans, but should be interpreted with caution given its preliminary nature. It is known that racial differences exist in how humans respond to development and progression of disease, therefore these data suggest that ethnicity of cell model may be important to consider with in vitroclinical research.",
author = "Feairheller, {Deborah L.} and Park, {Joon Young} and Kathleen Sturgeon and Williamson, {Sheara T.} and Diaz, {Keith M.} and Praveen Veerabhadrappa and Brown, {Michael D.}",
year = "2011",
month = "2",
day = "1",
doi = "10.1111/j.1752-8062.2011.00264.x",
language = "English (US)",
volume = "4",
pages = "32--37",
journal = "Clinical and Translational Science",
issn = "1752-8054",
publisher = "Wiley-Blackwell",
number = "1",

}

Racial differences in oxidative stress and inflammation : In vitro and in vivo. / Feairheller, Deborah L.; Park, Joon Young; Sturgeon, Kathleen; Williamson, Sheara T.; Diaz, Keith M.; Veerabhadrappa, Praveen; Brown, Michael D.

In: Clinical and Translational Science, Vol. 4, No. 1, 01.02.2011, p. 32-37.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Racial differences in oxidative stress and inflammation

T2 - In vitro and in vivo

AU - Feairheller, Deborah L.

AU - Park, Joon Young

AU - Sturgeon, Kathleen

AU - Williamson, Sheara T.

AU - Diaz, Keith M.

AU - Veerabhadrappa, Praveen

AU - Brown, Michael D.

PY - 2011/2/1

Y1 - 2011/2/1

N2 - African American race is an independent risk factor for enhanced oxidative stress and inflammation. We sought to examine whether oxidative-stress and inflammatory markers that are typically measured in humans also differ by race in cell culture. We compared levels between African American and Caucasian young adults and then separately in human umbilical vein endothelial cells (HUVECs) from both races. We found heightened oxidative stress and inflammation in the African Americans both in vitroand in vivo. African American HUVECs showed higher nitric oxide (NO) levels (10.8 ± 0.4 vs. 8.8 ± 0.7 μmol/L/mg, p= 0.03), Interleukin-6 (IL-6) levels (61.7 ± 4.2 vs. 23.9 ± 9.0 pg/mg, p= 0.02), and lower superoxide dismutase activity (15.6 ± 3.3 vs. 25.4 ± 2.8 U/mg, p= 0.04), and also higher protein expression (p< 0.05) of NADPH oxidase subunit p47phox, isoforms NOX2 and NOX4, endothelial nitric oxide synthase (NOS), inducible NOS, as well as IL-6. African American adults had higher plasma protein carbonyls (1.1 ± 0.1 vs. 0.8 ± 0.1 nmol/mg, p= 0.01) and antioxidant capacity (2.3 ± 0.2 vs. 1.1 ± 0.3 mM, p= 0.01). These preliminary translational data demonstrate a racial difference in HUVECs much like that in humans, but should be interpreted with caution given its preliminary nature. It is known that racial differences exist in how humans respond to development and progression of disease, therefore these data suggest that ethnicity of cell model may be important to consider with in vitroclinical research.

AB - African American race is an independent risk factor for enhanced oxidative stress and inflammation. We sought to examine whether oxidative-stress and inflammatory markers that are typically measured in humans also differ by race in cell culture. We compared levels between African American and Caucasian young adults and then separately in human umbilical vein endothelial cells (HUVECs) from both races. We found heightened oxidative stress and inflammation in the African Americans both in vitroand in vivo. African American HUVECs showed higher nitric oxide (NO) levels (10.8 ± 0.4 vs. 8.8 ± 0.7 μmol/L/mg, p= 0.03), Interleukin-6 (IL-6) levels (61.7 ± 4.2 vs. 23.9 ± 9.0 pg/mg, p= 0.02), and lower superoxide dismutase activity (15.6 ± 3.3 vs. 25.4 ± 2.8 U/mg, p= 0.04), and also higher protein expression (p< 0.05) of NADPH oxidase subunit p47phox, isoforms NOX2 and NOX4, endothelial nitric oxide synthase (NOS), inducible NOS, as well as IL-6. African American adults had higher plasma protein carbonyls (1.1 ± 0.1 vs. 0.8 ± 0.1 nmol/mg, p= 0.01) and antioxidant capacity (2.3 ± 0.2 vs. 1.1 ± 0.3 mM, p= 0.01). These preliminary translational data demonstrate a racial difference in HUVECs much like that in humans, but should be interpreted with caution given its preliminary nature. It is known that racial differences exist in how humans respond to development and progression of disease, therefore these data suggest that ethnicity of cell model may be important to consider with in vitroclinical research.

UR - http://www.scopus.com/inward/record.url?scp=79951899277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951899277&partnerID=8YFLogxK

U2 - 10.1111/j.1752-8062.2011.00264.x

DO - 10.1111/j.1752-8062.2011.00264.x

M3 - Article

VL - 4

SP - 32

EP - 37

JO - Clinical and Translational Science

JF - Clinical and Translational Science

SN - 1752-8054

IS - 1

ER -